Skip to main content

Advertisement

Log in

Augmentation cystoplasty: What are the indications?

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Augmentation cystoplasty has been studied and performed by urologists for more than 100 years. Although specific indications, techniques, and materials used have undergone major changes and revisions during this period, the general concepts have remained the same. Bladder augmentation increases the bladder’s storage capacity. Specific indications include structurally diminished bladder capacity, neurogenically incapacitated bladder, special circumstances of overactive bladder, and interstitial cystitis. This article briefly reviews techniques including laparoscopic and extraperitoneal approaches. Most common long-term consequences of bladder augmentation including chronic infections, bladder stones, perforation, and malignancy are described. Overall, we demonstrate that in appropriately selected patients, bladder augmentation presents an excellent treatment option to improve bladder capacity, achieve socially acceptable continence, and stabilize renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Tizzoni F: Die weiderherstellung der harnblase. Zentralbl Chir 1888, 15:921–924.

    Google Scholar 

  2. Mikulicz JA: I. Zur Operation der angeborenen Blasenspalte. Centralbl Chir 1899, 26:641–643.

    Google Scholar 

  3. Lay EB: Bladder made from gallbladder. Arch Ital di Chir 1925, 11:333–335.

    Google Scholar 

  4. Wein AJ: Pathophysiology and classification of voiding dysfunction. In Campbell-Walsh Urology, edn 9. Edited by Wein AJ, Kavoussi LR, Novick AC, et al. Philadelphia: Elsevier; 2007:1973–1985.

    Google Scholar 

  5. Wines MP, Lynch WD: A new minimally invasive technique for treating radiation cystitis: the argon-beam coagulator. BJU Int 2006, 98:610–612.

    Article  PubMed  Google Scholar 

  6. Blaivas JG, Weiss JP, Desai P, et al.: Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. J Urol 2005, 173:1631–1634.

    Article  PubMed  Google Scholar 

  7. Weld KJ, Dmochowski RR: Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urol 2000, 55:490–494.

    Article  PubMed  CAS  Google Scholar 

  8. Bauer SB, Hallet M, Khoshbin S, et al.: The predictive value of urodynamic evaluation in the newborn with myelodysplasia. JAMA 1984; 152:650.

    Article  Google Scholar 

  9. Gilbert SM, Hensle TW: Metabolic consequences and long-term complications of enterocystoplasty in children: a review. J Urol 2005, 173:1080–1086.

    Article  PubMed  Google Scholar 

  10. Atala A, Bauer SB, Soker S, et al.: Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367:1241–1246.

    Article  PubMed  Google Scholar 

  11. Razdan S, Leboeuf L, Meinbach DS, et al.: Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urol 2003, 61:893–896.

    Article  PubMed  Google Scholar 

  12. Dykstra DD, Sidi AA: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Archives of Physical Medicine and Rehabilitation 1990, 71:24–26.

    PubMed  CAS  Google Scholar 

  13. Schurch B, de Seze M, Denys P, et al.: Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005, 174:196–200.

    Article  PubMed  CAS  Google Scholar 

  14. Karsenty G, Reitz A, Lindemann G, et al.: Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urol 2006, 68:1193–1197.

    Article  PubMed  Google Scholar 

  15. Akbar M, Abel R, Seyler TM, et al.: Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int 2007, 100:639–645.

    Article  PubMed  Google Scholar 

  16. de Seze M, Wiart L, de Seze MP, et al.: Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 2004, 171:251–255.

    Article  PubMed  Google Scholar 

  17. Quek ML, Ginsberg DA: Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol 2003, 169:195–198.

    Article  PubMed  Google Scholar 

  18. Khastgir J, Hamid R, Arya M, et al.: Surgical and patient reported outcomes of “clam” augmentation ileocystoplasty in spinal cord injured patients. Eur Urol 2003, 43:263–269.

    Article  PubMed  CAS  Google Scholar 

  19. Turabelidze G, Schootman M, Zhu BP, et al.: Multiple sclerosis prevalence and possible lead exposure. J Neurol Sci 2008, 269:158–162.

    Article  PubMed  CAS  Google Scholar 

  20. Litwiller SE, Frohman EM, Zimmern PE: Multiple sclerosis and the urologist. J Urol 1999, 61:743–757.

    Google Scholar 

  21. Wyndaele JJ, Castro D, Madersbacher H, et al.: Neurogenic and faecal incontinence. In Incontinence. Edited by Abrams P, Cardozo L, Khoury S, Wein A. Paris: Health Publications; 2005:1059–1162.

    Google Scholar 

  22. Sirls LT, Zimmern PE, Leach GE: Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 1994, 151:946–950.

    PubMed  CAS  Google Scholar 

  23. Zommick JN, Simoneau AR, Skinner DG, Ginsberg DA: Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urol 2003, 169:2184–2187.

    Article  PubMed  Google Scholar 

  24. Nielsen KK, Kromann-Andersen B, Steven K, et al.: Failure of combined supratrigonal cystectomy and Mainz ileocecocystoplasty in intractable interstitial cystitis: is histology and mast cell count a reliable predictor for the outcome of surgery? J Urol 1990, 144:255–258.

    PubMed  CAS  Google Scholar 

  25. van Ophoven A, Oberpenning F, Hertle L: Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J Urol 2002, 167:603–607.

    Article  PubMed  Google Scholar 

  26. Kisman OK, Lycklama à Nijeholt AA, van Krieken JH: Mast cell infiltration in intestine used for bladder augmentation in interstitial cystitis. J Urol 1991, 146:1113–1114.

    PubMed  CAS  Google Scholar 

  27. Parsons CL, Bautista SL, Stein PC, et al.: Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 2000, 164:1381–1384.

    Article  PubMed  CAS  Google Scholar 

  28. Abrams P: Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urol 2003, 62:28–37.

    Article  PubMed  Google Scholar 

  29. Westney OL, Lee JT, McGuire EJ, et al.: Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy. J Urol 2002, 168:1044–1047.

    Article  PubMed  Google Scholar 

  30. Weil EH, Ruiz-Cerda JL, Eerdmans PH, et al.: Sacral root neuromodulation in the treatment of refractory urinary urge incontinence a prospective randomized clinical trial. Eur Urol 2000, 37:161–171.

    Article  PubMed  CAS  Google Scholar 

  31. Sahai A, Khan MS, Dasgupta P: Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 2007, 177:2231–2236.

    Article  PubMed  CAS  Google Scholar 

  32. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998, 81:569–573.

    PubMed  CAS  Google Scholar 

  33. Pope JC, Keating MA, Casale AJ, Rink RC: Augmenting the augmented bladder: treatment of the contractile bladder segment. J Urol 1998, 160:854–857.

    Article  PubMed  Google Scholar 

  34. Hafez AT, McLorie G, Gilday D, et al.: Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol 2003, 170:1639–1641.

    Article  PubMed  CAS  Google Scholar 

  35. Nurse DE, Mundy AR: Metabolic complications of cystoplasty. Br J Urol 1989, 63:165–170.

    Article  PubMed  CAS  Google Scholar 

  36. Plaire J, Snodgrass WT, Grady RW, Mitchell ME: Long-term followup of the hematuria-dysuria syndrome. J Urol 2000, 164:921–923.

    Article  Google Scholar 

  37. DeFoor W, Minevich E, Reeves D, et al.: Gastrocystoplasty: long-term followup. J Urol 2003, 170:1647–1649.

    Article  PubMed  Google Scholar 

  38. Albo ME, Raz S, Dupont MC: Anterior flap extraperitoneal cystoplasty. J Urol 1997, 157:2095–2098.

    Article  PubMed  CAS  Google Scholar 

  39. Gill IS, Rackley RR, Meraney AM, et al.: Laparoscopic enterocystoplasty. Urol 2000, 55:178–181.

    Article  PubMed  CAS  Google Scholar 

  40. Elliot SP, Meng MV, Anwar HP, Stoller ML: Complete laparoscopic ileal cystoplasty. Urol 2002, 59:939–943.

    Article  Google Scholar 

  41. Shpall AI, Ginsberg DA: Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup. J Urol 2004, 172:2296–2299.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David A. Ginsberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reyblat, P., Ginsberg, D.A. Augmentation cystoplasty: What are the indications?. Curr Urol Rep 9, 452–458 (2008). https://doi.org/10.1007/s11934-008-0078-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-008-0078-0

Keywords

Navigation